SERVICE

GenoBenet

GenoBenet—embracing your baby like a swaddling cloth.

With NGS-based genomic testing, GenoBenet enables the early detection of congenital disorders.

By analyzing newborn cord blood or heel-prick blood using next-generation sequencing (NGS), this test screens for congenital chromosomal disorders such as intellectual disability, developmental delay, and autism spectrum disorders.
Early detection of newborn conditions allows timely treatment and intervention to help reduce or manage symptoms.

Newborn Screening Test

Genomic screening for newborns

Why is the GenoBenet test important?

Many disorders caused by numerical or structural chromosomal abnormalities may not show visible symptoms at birth, making it easy to miss the critical window for treatment. The GenoBenet test enables the early detection of chromosomal disorders—including intellectual disability, developmental delay, autism, and ADHD—helping ensure timely treatment and ongoing care.

Intellectual disability

Developmental delay

Autism

ADHD

Who should consider the GenoBenet test?

  • Parents who wish to screen their baby’s genomic information early
  • Parents concerned about possible genetic factors affecting their child

How does the GenoBenet test detect chromosomal disorders?

Chromosomal Disorders

21th

Down syndrome

18th

Edwards syndrome

13th

Patau syndrome

XO

Turner syndrome

XXY

Klinefelter syndrome

XXX

Triple X syndrome

XYY

Jacobs syndrome

What chromosomal disorders can be detected?

The GenoBenet test analyzes all 23 pairs of chromosomes for trisomy, monosomy, and deletion/duplication regions.

Deletion: loss of part of a chromosome

Duplication: duplication of part of a chromosome

Disorders detectable by the GenoBenet test (including conditions registered under the Rare Disease Patient Support Program)

  • Major conditions : Through whole-genome sequencing (WGS), the GenoBenet test screens for a wide range of disorders that can occur across all chromosomes, including
  • 1p deletion syndrome
  • Joubert syndrome
  • WAGR syndrome
  • Dandy–Walker syndrome
  • Wolf–Hirschhorn syndrome
  • 12p duplication syndrome
  • Cri-du-chat syndrome
  • 6p deletion syndrome
  • Patau syndrome (Trisomy 13)
  • Currarino syndrome
  • Langer–Giedion syndrome
  • Prader–Willi syndrome
  • Kleefstra syndrome
  • 10q22–q23 deletion syndrome
  • 16p11.2 microdeletion syndrome
  • Smith–Magenis syndrome
  • Edwards syndrome (Trisomy 18)
  • 19p13.2 microdeletion syndrome
  • Alagille syndrome
  • Down syndrome (Trisomy 21)
  • Phelan–McDermid syndrome
  • Klinefelter syndrome (XXY)
  • Leri–Weill syndrome
  • Steroid sulfatase deficiency
  • Other conditions : The test also detects additional rare disorders such as 20p trisomy, 7q11.23 microduplication syndrome, Potocki–Lupski syndrome, Jacobsen syndrome, 8q21.11 microdeletion syndrome, among others, by analyzing the entire chromosomal landscape.

※ Note

The selection of GenoBenet test items is based on rare disease codes listed in Orphanet, the European reference database for rare diseases.

How is the GenoBenet test performed?

Sample collection

Heel-prick blood or cord blood sample

Transport

Secure delivery by a certified courier service

Testing

Next-generation sequencing (NGS) analysis

Results

Detection of congenital chromosomal disorders in newborns

Test Information

Test name Newborn Genomic Screening Test (NBS) (NBS, Newborn Screening Test)
Method Next-generation sequencing (NGS) (NGS, Next Generation Sequencing)
Test items Detection of congenital chromosomal abnormalities that may occur across the entire genome
Testing period From birth onward
Specimen information Heel-prick blood dried blood spot (minimum 2 spots)
Cord blood ≥3 mL (EDTA tube, recommended)
Whole blood ≥0.25 mL (EDTA tube)
Turnaround time Within 14 days (from the date of receipt)

Test Limitations

  • This test screens for chromosomal abnormalities using next-generation sequencing (NGS) combined with advanced bioinformatics analysis.
  • The test reports numerical chromosomal abnormalities (aneuploidy) as well as segmental aneuploidies involving chromosomal regions larger than 5 Mb.
  • It does not detect balanced translocations, balanced inversions, single nucleotide variants, or low-level mosaicism (<20%).
  • If chromosomal abnormalities are detected, confirmatory diagnostic testing is required.
  • Genetic counseling is recommended both before and after testing.

What if chromosomal abnormalities are detected in the GenoBenet test?

Receive confirmatory testing and rare disease diagnosis

If the GenoBenet test result is Detected, confirmatory testing (such as chromosomal microarray test) must be performed, and after final confirmation of the diagnostic result of the disease, genetic counseling is necessary.

Register as a special case under the National Health Insurance

If the GenoBenet test result is Detected, confirmatory testing (such as chromosomal microarray test) must be performed, and after final confirmation of the diagnostic result of the disease, genetic counseling is necessary.

Search the Rare Disease Helpline

On the Korea Disease Control and Prevention Agency Rare Disease Helpline (https://helpline.kd-ca.go.kr/cdchelp/), you can access information on rare diseases. It provides details on symptoms, causes, specialized institutions, and statistical data for more than 1,300 rare diseases, as well as information on medical expense support programs and genetic testing support programs.

Register for the medical expense support program

Medical expenses for more than 1,300 rare diseases are supported in Korea. After registering as a special case, both online application and offline application through public health centers are possible.

Proceed with confirmatory testing

Register as a special case beneficiary

Apply for the rare disease medical expense support program

Check GenoBenet test results

The GenoBenet test report is provided as a premium booklet of approximately 40 pages.

LIMS Access Precision GenoMom GenoBro ora™

Privacy Policy

The company informs customers through the Privacy Policy about how the personal information provided is used and what measures are taken to protect personal information.

Purpose of Collecting and Using Personal Information

- Identifying individuals, verifying real names, confirming intent to sign up, and ensuring age-restricted service usage based on service use.
- Fulfilling contracts related to service provision, such as billing for services provided, delivering content, purchasing and processing payments, and dispatching items or billing statements.
- Delivering notices, ensuring communication for handling complaints, and ensuring accurate delivery information for item shipments.
- Providing information on new services and offering personalized services.
- Facilitating smooth provision of high-quality services.

Personal Information Collected

- Name, company name, email, address, contact number, mobile phone number, inquiry details, and other optional items.

Retention and Use Period of Personal Information

- As a general rule, personal information is destroyed immediately once the purpose for its collection or provision has been fulfilled.
- However, for the purpose of ensuring smooth service consultations, the content of the consultation may be retained for 3 months after completion. In cases where other laws, such as the Act on the Consumer Protection in Electronic Commerce, require preservation, the information may be retained for a specified period.

Procedure and Method for Destroying Personal Information

The company, as a general rule, destroys personal information without delay after the purpose of collection and use has been fulfilled. Information entered for membership or other purposes is transferred to a separate database (or, in the case of paper records, to a separate file) and stored for a certain period according to internal policies and relevant laws before being destroyed. Personal information transferred to a separate database is not used for any other purpose unless required by law. Personal information stored in electronic file formats is deleted using technical methods that prevent the recovery of the records.

Refusal of Unauthorized E-mail Collection

GENOMECARE prohibits unauthorized email collection.

The collection of email addresses posted on this website using email collection programs or other technical devices is prohibited, and violators may be punished under the Act on Promotion of Information and Communications Network Utilization and Information Protection.